Copyright
©2010 Baishideng.
World J Gastroenterol. Apr 28, 2010; 16(16): 2010-2016
Published online Apr 28, 2010. doi: 10.3748/wjg.v16.i16.2010
Published online Apr 28, 2010. doi: 10.3748/wjg.v16.i16.2010
Table 1 Baseline characteristics of subjects in the NaP, PEG and control groups n (%)
Characteristics | NaP group (n = 224) | PEG group (n = 113) | Control group (n = 672) | P |
Age (yr) | 46.9 ± 8.6 | 51.1 ± 10.5 | 46.9 ± 8.6 | < 0.001 |
Gender | 0.453 | |||
Male | 149 (67) | 81 (72) | 475 (71) | |
Female | 75 (33) | 32 (28) | 197 (29) | |
Body mass index (kg/m2) | 23.4 ± 3.1 | 23.8 ± 2.7 | 23.6 ± 2.9 | 0.496 |
Hypertension | 50 (22) | 34 (30) | 188 (28) | 0.186 |
Diabetes mellitus | 29 (13) | 23 (20) | 134 (20) | 0.056 |
Serum phosphate1 (mg/dL) | 88.9 ± 14.5 | 95.3 ± 17.4 | 91.6 ± 17.4 | 0.004 |
- Citation: Seol DC, Hong SN, Kim JH, Sung IK, Park HS, Lee JH, Shim CS. Change in renal function after sodium phosphate preparation for screening colonoscopy. World J Gastroenterol 2010; 16(16): 2010-2016
- URL: https://www.wjgnet.com/1007-9327/full/v16/i16/2010.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i16.2010